Zhou Qiang, Yik Jasper H N
Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3202, USA.
Microbiol Mol Biol Rev. 2006 Sep;70(3):646-59. doi: 10.1128/MMBR.00011-06.
The positive transcription elongation factor b (P-TEFb) stimulates transcriptional elongation by phosphorylating the carboxy-terminal domain of RNA polymerase II and antagonizing the effects of negative elongation factors. Not only is P-TEFb essential for transcription of the vast majority of cellular genes, but it is also a critical host cellular cofactor for the expression of the human immunodeficiency virus (HIV) type 1 genome. Given its important role in globally affecting transcription, P-TEFb's activity is dynamically controlled by both positive and negative regulators in order to achieve a functional equilibrium in sync with the overall transcriptional demand as well as the proliferative state of cells. Notably, this equilibrium can be shifted toward either the active or inactive state in response to diverse physiological stimuli that can ultimately affect the cellular decision between growth and differentiation. In this review, we examine the mechanisms by which the recently identified positive (the bromodomain protein Brd4) and negative (the noncoding 7SK small nuclear RNA and the HEXIM1 protein) regulators of P-TEFb affect the P-TEFb-dependent transcriptional elongation. We also discuss the consequences of perturbations of the dynamic associations of these regulators with P-TEFb in relation to the pathogenesis and progression of several major human diseases, such as cardiac hypertrophy, breast cancer, and HIV infection.
正性转录延伸因子b(P-TEFb)通过磷酸化RNA聚合酶II的羧基末端结构域并拮抗负性延伸因子的作用来刺激转录延伸。P-TEFb不仅对绝大多数细胞基因的转录至关重要,而且是人类免疫缺陷病毒1型(HIV-1)基因组表达的关键宿主细胞辅因子。鉴于其在全局影响转录中的重要作用,P-TEFb的活性受到正性和负性调节因子的动态控制,以便与整体转录需求以及细胞的增殖状态同步实现功能平衡。值得注意的是,响应于最终可影响细胞生长与分化之间决定的多种生理刺激,这种平衡可向活性或非活性状态转变。在本综述中,我们研究了最近鉴定出的P-TEFb的正性调节因子(含溴结构域蛋白Brd4)和负性调节因子(非编码7SK小核RNA和HEXIM1蛋白)影响P-TEFb依赖性转录延伸的机制。我们还讨论了这些调节因子与P-TEFb的动态关联受到干扰后,与几种主要人类疾病(如心肌肥大、乳腺癌和HIV感染)的发病机制和进展相关的后果。